Financial Enhancement Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,616
| Closed | -$3.95M | – | 149 |
|
|
2024
Q3 | $3.95M | Buy |
+18,616
| New | +$3.95M | 0.77% | 42 |
|
|
2023
Q2 | – | Sell |
-18,616
| Closed | -$3.95M | – | 132 |
|
|
2023
Q1 | $3.95M | Buy |
18,616
+1,567
| +9% | +$332K | 0.77% | 42 |
|
|
2022
Q4 | $4.31M | Buy |
17,049
+279
| +2% | +$70.5K | 0.83% | 46 |
|
|
2022
Q3 | $3.51M | Buy |
16,770
+244
| +1% | +$51.1K | 0.81% | 31 |
|
|
2022
Q2 | $3.89M | Buy |
+16,526
| New | +$3.89M | 0.84% | 31 |
|